Literature DB >> 25488143

Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 2. Inclusion mode and stability studies.

Cassiana Mendes1, Aline Buttchevitz, Andersson Barison, Fernanda Maria Marins Ocampos, Larissa Sakis Bernardi, Paulo Renato Oliveira, Marcos Antônio Segatto Silva.   

Abstract

INTRODUCTION: Norfloxacin (NFX) is a broad spectrum antibiotic with low solubility and permeability, which is unstable on exposure to light and humidity.
OBJECTIVE: In this study, the mode of NFX inclusion into β-cyclodextrin complexes was evaluated and a complete physical, chemical and microbiological stability study of the inclusion complexes was carried out.
METHODS: Potentiometric titrations were performed to evaluate changes in the pKa of the NFX molecule due to the formation of an inclusion complex and NMR analysis demonstrated that the NFX molecule is included in the β-cyclodextrin cavity.
RESULTS: Inclusion complexes obtained by kneading followed by freeze-drying showed improved NFX stability compared with the isolated drug or the physical mixture. This method was effective in terms of protecting the drug from photodegradation and also avoiding hydrolysis. Differences between NFX and the complexes could be evidenced by thermal analysis, infrared spectroscopy and x-ray powder diffraction as well as by determining the solubility and drug content. The antimicrobial potency was also preserved on applying the promising method of kneading.
CONCLUSION: The satisfactory stability indicates that the NFX/β-cyclodextrin complexes could be useful as an alternative to the existing NFX drug formulation.

Entities:  

Keywords:  inclusion complexes; inclusion mode; norfloxacin; stability studies; β-cyclodextrin

Mesh:

Substances:

Year:  2015        PMID: 25488143     DOI: 10.1586/14787210.2015.982092

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  2 in total

1.  Computational investigation on the host-guest inclusion process of norfloxacin into β-cyclodextrin.

Authors:  Pollyanna P Maia; Sara Maria R de Sousa; Wagner B De Almeida; Luciana Guimarães; Clebio S Nascimento
Journal:  J Mol Model       Date:  2016-08-24       Impact factor: 1.810

Review 2.  Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.

Authors:  Dariusz Boczar; Katarzyna Michalska
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.